Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 950.00
+98.00 (11.50%)
At close: Jul 21, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 57.99 billion as of July 21, 2026. Its market cap has increased by 59.45% in one year.
Market Cap
57.99B
Enterprise Value
48.52B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
950.00
ChartMarket Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 57.99B, a decrease of -75.32%. That is a compound annual growth rate of -21.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 57.99B | 90.03% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AriBioLab | 67.82B |
| EyeGene | 64.46B |
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |
| ABION | 60.82B |
| Naturalendo Tech | 56.64B |
| ADBiotech | 52.80B |
| Psomagen | 51.84B |